Welcome to the Belgian Association for the Study of the Liver.

Hot News

• For antiprotease use:
  see all the drug-drug interactions on www.hep-druginteractions.org
• An extension of the registry of hepatitis delta is open. Please find all the information and all the documents (form to fill, informed consents, ethics committee approval) on "Registers" (for members only).
  
• The reports of the 2011 Winter Meeting and Liver Course are on-line here (for members only).
  
• Reimbursement criteria and forms for Hep. B: Baraclude, Hepsera, Viread, Pegasys and Zeffix, and for Hep. C Pegasys and Pegasys + Copegus: see page Reimbursements
  
• Rules for reimbursement of Hep. C quantitative PCR (since 1.12.2009) : 4 tests authorized per treatment: this allows you to have a test at week 4 !
  
• A BASL trial for the treatment of acute alcolholic hepatitis is launched.
• The BASL offers awards :
  • for a case presentation at the Winter Meeting
  • for clinical and basic presentations at the Spring Meeting
  • for clinical and basic publications (with MSD sponsoring)
  • research grants
  • more info here.
    
• Ask for your login and password to access the protected zones of our site (for BASL members only) here.
  To become a BASL member click here.
  

• Become a member of the European Association for the Study of the Liver too !
  Benefits:
  • Reduced rate registration to the annual EASL meetings
  • Reduced rate registration to the EASL monothematic meetings
  • Fellowship schemes, bursaries, access to EASL training schemes
  • Free subscription to the Journal of Hepatology, and EASL newsletter
  • Webcast of EASL meetings
  
  Register on www.easl.eu

The BASL is supported by an unrestricted grant from its major sponsors (by alphabetical order) :